Xenon Pharmaceuticals Inc. (NASDAQ:XENE) is a biotech stock that has almost doubled in the past month. This is a definition of hot stock in the biotechnology industry, which can be very volatile and heavily driven by news-driven factors. According to MarketWatch, Xenon’s “products include XEN496, XEN1101, XEN901, and XEN007.” And the big, price-driving news lately…

Xenon Pharmaceuticals (NASDAQ:XENE) was having a pretty quiet 2021. For most of the year, XENE stock traded between $15 and $20 with minimal volatility. However, that changed in a hurry early in October. Source: Iryna Imago / Shutterstock.com Xenon announced unexpectedly strong results from its mid-stage Phase II focal epilepsy study. XENE stock surged 80%…

Neurology focused biopharmaceutical company Xenon Pharmaceuticals (NASDAQ:XENE) doesn’t have a giant market capitalization, but it does offer ambitious clinical programs. As for XENE stock, the share price drifted sideways for a long time — but now, the trajectory is definitely to the upside. Source: luchschenF / Shutterstock.com Just to recap, Xenon specializes in areas of high…